Torii Pharmaceutical Co., Ltd.

TSE:4551.T

4250 (JPY) • At close November 8, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) JPY.

20232022202120202019201820172016201520142013201220112010200920082007200620052004
Operating Activities:
Net Income 4,1195,7224,7674,22537,7003,0306,3734,0565,2583,7815,1332,9295,0541,8396,3406,0385,3785,4347,53710,115
Depreciation & Amortization 2354544135829851,0401,1741,3391,4579241,0891,0611,1941,3941,4091,4171,2201,1331,006958
Deferred Income Tax 00000000000000000000
Stock Based Compensation 00000000000000000000
Change In Working Capital -7,469-1,157-5,6492,1872,4233,530685243-793-4,646-5,746-1,325-1,323-1,007-2,420-1,009-56-126-1,058-903
Accounts Receivables -5,638-854-3,0526,1931,9861,985-2,5621,344-2,003-2,311.9990-668-1,1450000000
Inventory -1,772-206-1,6103608011,811480-770299-2,107-498-1,187-965215-362-1,326-335439-1,112278
Accounts Payables 396791649-609-904-1,5851,544-15575800000000000
Other Working Capital -455-888-1,636-3,7575401,7192051,013-1,092-2,5390-138-358-1,222-2,058317279-56554-1,181
Other Non Cash Items -8-2,599313-10,4371,391659-1,883-2,236-982-668278-2,514-1,885-2,742-331-3,186-3,210-3,027-4,060-4,580
Operating Cash Flow -3,1232,420-156-3,44342,4998,2596,3493,4024,940-609-2011513,040-5164,9983,2603,3323,4143,4255,590
Investing Activities:
Investments In Property Plant And Equipment -216-281-374-411-546-675-789-760-1,484-884-811-1,350-683-829-1,283-1,040-1,324-1,756-1,044-870
Acquisitions Net 00-2241,100-126147-258-159-47-32925-176-227-276-214406-137-604-21433
Purchases Of Investments -26,589-31,445-24,476-38,844-43,566-34,158-10,105-1,611-500-3,110-8,701-44,990-51,515-32,379-4,806-1,295-1,398-1,986-3,102-7,695
Sales Maturities Of Investments 23,02717,66423,78045,78246,2037,7403,3003,6172,6004,50027,20047,20055,35515,8831,6971,8961,5422,3015,2524,700
Other Investing Activites -1386-204-2134-122259274388322-7190221-3,701-5,7902612,138-1,392-788-496
Investing Cash Flow -3,779-13,676-1,4987,6252,099-27,068-7,5931,36195749917,7068743,151-21,302-10,396228821-3,437104-4,328
Financing Activities:
Debt Repayment -293-348-198-85-85-85-198-315-3350000000000-200
Common Stock Issued 000885000000000000000
Common Stock Repurchased 00085-10-1-615-2-1-100-1-1-2-1-1-3-4
Dividends Paid -3,540-1,348-1,348-1,347-1,347-1,346-1,346-1,358-1,245-1,132-1,132-1,132-1,132-1,188-1,103-905-735-735-792-622
Other Financing Activities -2-2-198-86-85-86-199-316-335-278-1-49-22-54-78-83-1-1-1-1
Financing Cash Flow -3,835-1,698-1,546-1,425-1,433-1,432-1,546-2,289-1,582-1,410-1,319-1,181-1,154-1,243-1,182-990-737-737-796-827
Other Information:
Effect Of Forex Changes On Cash -29,6790-20000110021-1-10000-1
Net Change In Cash -10,739-12,954-3,2022,75743,165-20,241-2,7902,4754,316-1,52016,186-1545,038-23,062-6,5812,4983,416-7602,733434
Cash At End Of Period 34,68145,42058,37461,57658,81915,65435,89538,68536,21031,89433,41417,22817,38212,34435,40641,98739,48936,07336,83334,100